Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ANIK

Anika Therapeutics (ANIK)

Anika Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANIK
DateTimeSourceHeadlineSymbolCompany
24/12/202408:01GlobeNewswire Inc.Anika To Participate in 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ANIKAnika Therapeutics Inc
23/11/202408:16GlobeNewswire Inc.Anika To Participate in December 2024 Investor ConferencesNASDAQ:ANIKAnika Therapeutics Inc
09/11/202406:17Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
05/11/202408:41Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANIKAnika Therapeutics Inc
01/11/202402:00PR Newswire (US)Arthrosurface Returns to it Roots Following Divestiture from Anika TherapeuticsNASDAQ:ANIKAnika Therapeutics Inc
31/10/202422:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
31/10/202422:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
31/10/202422:05GlobeNewswire Inc.Anika Reports Third Quarter 2024 Financial ResultsNASDAQ:ANIKAnika Therapeutics Inc
31/10/202422:00GlobeNewswire Inc.Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus MedicalNASDAQ:ANIKAnika Therapeutics Inc
24/10/202408:04Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
18/10/202407:01GlobeNewswire Inc.Anika Announces Third Quarter 2024 Results Conference Call DateNASDAQ:ANIKAnika Therapeutics Inc
05/10/202406:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIKAnika Therapeutics Inc
05/10/202406:01GlobeNewswire Inc.Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ANIKAnika Therapeutics Inc
10/09/202406:45GlobeNewswire Inc.Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ANIKAnika Therapeutics Inc
16/08/202406:01GlobeNewswire Inc.Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ANIKAnika Therapeutics Inc
09/08/202407:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANIKAnika Therapeutics Inc
09/08/202406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
09/08/202406:05GlobeNewswire Inc.Anika Reports Second Quarter 2024 Financial ResultsNASDAQ:ANIKAnika Therapeutics Inc
06/08/202406:01GlobeNewswire Inc.Anika to Participate in the Sidoti Virtual Investor ConferenceNASDAQ:ANIKAnika Therapeutics Inc
25/07/202423:00GlobeNewswire Inc.Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024NASDAQ:ANIKAnika Therapeutics Inc
16/07/202421:19GlobeNewswire Inc.Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ANIKAnika Therapeutics Inc
12/07/202406:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIKAnika Therapeutics Inc
12/07/202406:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIKAnika Therapeutics Inc
12/07/202406:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIKAnika Therapeutics Inc
12/07/202406:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIKAnika Therapeutics Inc
12/07/202406:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIKAnika Therapeutics Inc
12/07/202406:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIKAnika Therapeutics Inc
12/07/202406:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIKAnika Therapeutics Inc
12/07/202406:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIKAnika Therapeutics Inc
12/07/202406:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ANIK